Dr. Gilad Mensky

Gilad Mensky is a clinical researcher affiliated with Chris Hani Baragwanath Academic Hospital in Johannesburg, South Africa, contributing to the fields of critical care and infectious diseases. His work is closely aligned with frontline hospital practice, particularly during the COVID-19 pandemic, where he has examined therapeutic strategies and diagnostic tools within resource-constrained settings.

His research explores the clinical effectiveness of high-dose intravenous immunoglobulin as salvage therapy in severe COVID-19, with careful evaluation of organ dysfunction, oxygenation parameters, and patient outcomes in intensive care. In parallel, he has assessed the validity of rapid antibody testing for COVID-19, highlighting the practical limitations and appropriate contexts for serological diagnostics.

Across the available publications, his scholarship demonstrates strengths in clinical study design, critical appraisal of emerging interventions, and evidence-based evaluation of diagnostic technologies. As the current body of work is limited, this profile reflects insights drawn from a focused but meaningful contribution to pandemic-related critical care research.